[PDF] Top 20 Análisis del estrés térmico en los trabajadores de la empresa “APRODEMAG”.
Has 10000 "Análisis del estrés térmico en los trabajadores de la empresa “APRODEMAG”." found on our website. Below are the top 20 most common "Análisis del estrés térmico en los trabajadores de la empresa “APRODEMAG”.".
An Atypical Cause Of Atypical Hemolytic Uremic Syndrome
... for Hemolytic Uremic Syndrome(HUS) was commenced and eventually ECOLI, Shigella, Streptococcus, Influenza and RSV infections were all ruled ...14 Atypical Hemolytic Uremic ... See full document
20
Factor H autoantibodies and deletion of Complement Factor H Related protein 1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome
... pathway [5]. Factor I (FI) is a serine protease that inhibits all complement pathways but works only in the presence of its specific cofactors, such as FH and C4BP [6,7]. Defective activation of complement as well as ... See full document
8
Role of eculizumab in a pediatric refractory gemcitabine induced thrombotic microangiopathy: a case report
... Eculizumab is a monoclonal antibody directed against C5 complement protein preventing formation of C5a and C5b-9 membrane-attack complex [1]. It shows a low toxicity profile and seems to be well tolerated in patients ... See full document
23
The spectrum of renal thrombotic microangiopathy in lupus nephritis
... especially atypical hemolytic uremic syndrome (aHUS), one of the reasons for TMA, we further detected concentrations of serum factor H in our ... See full document
14
Plasma complement factor H is associated with disease activity of patients with ANCA associated vasculitis
... aHUS: Atypical hemolytic uremic syndrome; ANCA: Anti-neutrophil cytoplasmic antibody; ANOVA: Analysis of variance; AUC: Area under the curve; BSA: Bovine serum albumin; BVAS: Birmingham ... See full document
22
Severe Combined Immunodeficiency Resulting From Mutations in MTHFD1
... leukopenia, atypical hemolytic uremic syndrome, and neurologic abnormalities in which hydroxocobalamin and folate therapy provided partial immune ...genetic cause of SCID and the ... See full document
8
Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome
... Genetic testing is important in the care of patients with atypical hemolytic uremic syndrome because prognosis can vary depending on the gene mutations involved. For example, CFH mutations, ... See full document
131
Acquired thrombotic thrombocytopenia purpura associated with severe ADAMTS13 deficiency in a 3 year old boy: a case report and review of the literature
... (hemolytic-uremic syndrome) Registry reported that the incidence rate of TTP in chil- dren was ...Evans syndrome, atypical HUS (aHUS), or ... See full document
23
Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report
... microangiopathic hemolytic anemia improved and renal function subsequently recovered des- pite three months of hemodialysis, as has been reported in other cases ... See full document
29
Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab
... Abstract: Atypical hemolytic uremic syndrome (aHUS) is a rare disease caused by chronic, uncontrolled activation of the alternative complement pathway, leading to thrombotic ... See full document
5
<p>Epidemiology of Atypical Hemolytic Uremic Syndrome: A Systematic Literature Review</p>
... Abstract: Atypical hemolytic uremic syndrome (aHUS) is a rare but severe disorder that frequently has a genetic component and results from the overactivation of the alternative complement ... See full document
10
Preservation of Renal Function in Atypical Hemolytic Uremic Syndrome by Eculizumab: A Case Report
... In March 2010, the clinical status of the patient worsened dramatically, with persistent vomiting, sweating, an- orexia, and drowsiness without neu- rologic impairments. Hemodialysis was started (serum creatinine 2.51 ... See full document
6
Successful use of eculizumab to treat atypical hemolytic uremic syndrome in patients with inflammatory bowel disease
... Background: Atypical hemolytic uremic syndrome is a rare group of disorders that have in common underlying complement amplifying ...in atypical hemolytic uremic ... See full document
16
Enterohemorrhagic Escherichia coli associated with hemolytic uremic syndrome in Chilean children
... A DNA probe to identify enterohemorrhagic Escherichia coli of 0157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome.. Hemolytic-uremic syndrome: an ana[r] ... See full document
9
Eculizumab in Anti-Factor H Antibodies Associated With Atypical Hemolytic Uremic Syndrome
... We also show how the ef fi cacy of eculizumab is highly dependent on the dose and frequency of adminis- tration. The incidence of ischemic heart involvement in aHUS has rarely been reported up to now, perhaps be- ... See full document
6
Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome: Syndromes or Diseases?
... HELLP syndrome, the most cause of MAHA and thrombocytopenia during pregnancy, may account for a larger fraction of the cases encountered at institutions with busy obstetric ... See full document
12
Cryptic Activity of Atypical Hemolytic Uremic Syndrome and Eculizumab Treatment
... Global complement functions, as mea- sured by the AP50 and CH50 (Unit of al- ternative and classic pathways activity, respectively), were completely suppressed by ECU (from a mean value of 82.0% 6 6.0% and 110.0% 6 4.4% ... See full document
5
Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities
... be involved [1]. Non-STEC causes of HUS or atypical HUS (aHUS) are typically associated with mutations in regulatory proteins of the complement system in chil- dren. More importantly, aHUS is associated with in- ... See full document
6
Peripheral Gangrene in Children With Atypical Hemolytic Uremic Syndrome
... Atypical hemolytic uremic syndrome (aHUS) is a thrombotic micro- angiopathy with severe clinical manifestation, frequent recurrence, and poor long-term ... See full document
34
Eculizumab as First-Line Therapy for Atypical Hemolytic Uremic Syndrome
... unique cause of TMA is identi fi ed as mutations in DGKE or a de fi ciency in cobalamin metabolism, we nevertheless recom- mend that eculizumab treatment be started as soon as aHUS is ... See full document
25
Related subjects